Full Breakdown
Investigation into Breast Cancer Care at County Durham and Darlington NHS Trust
12/2/2025, 12:59:15 PM
Overview of the Investigation
An investigation into the County Durham and Darlington Foundation Trust (CDDFT) has revealed serious shortcomings in the management of breast cancer care, leading to unnecessary mastectomies, delayed diagnoses, and inadequate patient support. The inquiry, which encompasses over 200 cases, has identified 43 instances of significant harm and is examining one death linked to the trust's practices.
Key Findings from the Aubrey Review
The independent review conducted by governance specialist Mary Aubrey highlighted persistent concerns regarding CDDFT's breast cancer services dating back to 2012, when the trust lost its status as a training center for breast surgery. The review criticized outdated clinical practices that failed to meet best practice guidelines, resulting in delayed diagnoses and missed cancers. It also noted a high rate of re-excision procedures and a low rate of immediate breast reconstruction following mastectomy, with only 7.5% of mastectomies at CDDFT followed by reconstruction, compared to the national minimum recommendation of 25%.
Patient Experiences and Complaints
Patients have reported feeling "butchered" by the surgical procedures they underwent. Kate Driver, a 31-year-old patient, experienced significant delays in her diagnosis and was advised against immediate breast reconstruction after her mastectomy. She later sought a second opinion, which confirmed that reconstruction was indeed an option. Another patient, Dawn Gillott, expressed feelings of having no choice in her treatment, stating, "I felt like I didn't have a choice. It was 'you're having this and that's all there is to it'." Both women have raised formal complaints regarding their treatment.
Conflicts of Interest and Financial Concerns
The investigation revealed that CDDFT paid nearly £6 million to private clinics run by Mr. Amir Bhatti, the trust's clinical lead for breast surgery, raising concerns about conflicts of interest. Between 2022 and 2024, a significant number of patients were referred to private clinics for urgent investigations, which were financially incentivized on a per-patient basis.
Official Responses and Future Actions
CDDFT has publicly apologized to affected patients, acknowledging that "over many years, warning signs were repeatedly missed or not acted upon." The trust's leadership has undergone changes, with a new chief executive and interim chair appointed to address the identified issues. NHS England has pledged support for the new leadership to implement necessary improvements.
Criticism of Surgical Practices
The Royal College of Surgeons (RCS) reported serious concerns regarding the speed and quality of surgical procedures at CDDFT, noting that some mastectomies were performed in as little as 28 minutes. The RCS described the situation as an "appalling indictment" of the trust's breast clinic service, emphasizing that many procedures were conducted incorrectly.
Verbatim Quotes
- "Waiting so long and having to chase everything up made it a hundred times worse than it needed to be." — Kate Driver, Patient
- "I felt like I didn't have a choice. It was 'you're having this and that's all there is to it'." — Dawn Gillott, Patient
- "It is true to say that there were a number of missed opportunities. It was not good enough." — Kathryn Burn, Executive Director of Nursing, CDDFT
- "Serving the best interests of all our patients is of paramount importance." — Amir Bhatti, Clinical Lead, CDDFT
Conclusion
The ongoing investigation into CDDFT's breast cancer services underscores the critical need for systemic changes in patient care protocols and oversight to prevent further harm to patients. The revelations have prompted a reevaluation of practices and a commitment to improving standards within the trust.
